Search Results
Nov 25, 2025, 07:30 ET Medicare Finalizes Reimbursement for Caristo's CaRi-Plaque™ Across Hospital and Office Settings
The decision completes the two major Medicare reimbursement pathways for nationwide use of CaRi-Plaque. Based on a new Category I CPT® code (75577) for AI quantification and characterization of coronary atherosclerotic plaque derived from analysis of CCTA, CMS recently set a 2026 Physician
More news about: CARISTO DIAGNOSTICS
Nov 24, 2025, 08:00 ET Sera Announces Publication Acceptance for PRIME Study
market growth; potential third-party payer coverage and reimbursement; new reimbursement methodologies applicable to the PreTRM Test, including new CPT codes and payment rates for those codes; changes in FDA regulation of laboratory-developed tests; the intellectual property rights protecting our tests
More news about: Sera Prognostics, Inc.
Nov 21, 2025, 10:05 ET UPCOMING DEADLINE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Inspire Medical Systems
onboarding needed to begin using the product. Inspire also disclosed billing and reimbursement challenges, explaining that although Medicare had approved a CPT code for Inspire V, the necessary software updates for claims processing did not go into effect until July 1. As a result, implanting centers could not
More news about: Faruqi & Faruqi, LLP
Nov 19, 2025, 08:54 ET IceCure Reports Financial & Operational Results for the Nine Months Ended September 30, 2025
early-stage breast cancer, post-market activity, and recommendations from professional medical associations. ProSense® currently has reimbursement under the CPT III code which covers $3,800 of facility costs, which is expected to increase to slightly over $4,000 effective January 2026.
More news about: IceCure Medical
Nov 19, 2025, 08:46 ET CMS Establishes National Pricing for Vesiflo's inFlow™ Voiding Prosthesis
inFlow™ Voiding Prosthesis, following the Centers for Medicare & Medicaid Services (CMS) decision to establish national pricing for the CPT® codes related to physician procedures for the device. This decision, included in the Calendar Year 2026 Medicare Physician Fee Schedule (PFS) Final
More news about: Vesiflo
Nov 18, 2025, 11:03 ET Inspire Medical Systems, Inc. (INSP) Faces Investor Suit Over Disastrous Inspire V Launch-- Hagens Berman
onboarding criteria required prior to the purchase and implant of Inspire V." The company also said that, although Inspire V's CPT code was approved for Medicare patients, "software updates for claims submissions and processing did not take effect until July 1." This meant that
More news about: Hagens Berman Sobol Shapiro LLP
Nov 14, 2025, 12:30 ET Intrinsic Therapeutics Announces the First Endoscopic Barricaid Implantation in the Great Lakes Region by Dr. Nick Nenadovich
multicenter, Level I RCT demonstrating superior outcomes to discectomy alone was published in JAMA with five-year follow-up results. A new Category I CPT Code 63032 for bone-anchored annular closure will go into effect on January 1, 2026. *Some studies are outside FDA indications.
More news about: Intrinsic Therapeutics, Inc.
Nov 14, 2025, 10:26 ET INSP DEADLINE: Faruqi & Faruqi Reminds Inspire Medical Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of January 5, 2026 - INSP
onboarding needed to begin using the product. Inspire also disclosed billing and reimbursement challenges, explaining that although Medicare had approved a CPT code for Inspire V, the necessary software updates for claims processing did not go into effect until July 1. As a result, implanting centers could not
More news about: Faruqi & Faruqi, LLP
Nov 13, 2025, 16:05 ET SERA PROGNOSTICS REPORTS THIRD QUARTER 2025 FINANCIAL RESULTS
market growth; potential third-party payer coverage and reimbursement; new reimbursement methodologies applicable to the PreTRM Test, including new CPT codes and payment rates for those codes; changes in FDA regulation of laboratory-developed tests; the intellectual property rights protecting our tests
More news about: Sera Prognostics, Inc.
Nov 13, 2025, 10:37 ET BOOST TREADMILLS LAUNCHES BOOST 3: REVOLUTIONARY MICROGRAVITY TREADMILL MAKES ELITE PERFORMANCE AND RECOVERY ACCESSIBLE TO HOMES AND CLINICS
bracket). Insurance Support: The company provides assistance with Letters of Medical Necessity and CPT coding guidance for clinics. Many insurance plans may cover 40-60% of costs for individuals when prescribed by a physician for qualifying conditions.
More news about: Boost Treadmills
Nov 13, 2025, 08:25 ET Shareholders who lost money in shares of Inspire Medical Systems, Inc. (NYSE: INSP) Should Contact Wolf Haldenstein Immediately
device. Billing and Medicare Reimbursement Issues: Although Inspire V's CPT code was approved for Medicare, billing software updates did not take effect until July 1, delaying claims and reimbursement processing.→
More news about: Wolf Haldenstein Adler Freeman & Herz LLP
Nov 11, 2025, 10:13 ET Olympus Corporation Announces Newest Appointments to Help Drive Innovation and Patient Safety for Respiratory Business
in his work with the American Thoracic Society/American College of Chest Physicians Clinical Practice Committee on writing and valuing bronchoscopy CPT codes, including those for endobronchial ultrasound (EBUS) and navigational bronchoscopy. Along with transforming the Cleveland
More news about: Olympus Corporation of the Americas
Nov 10, 2025, 13:32 ET Robbins Geller Rudman & Dowd LLP Announces that Inspire Medical Systems, Inc. (INSP) Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
implant of [Inspire V]," the complaint alleges. Defendants further admitted that, although Inspire V's CPT code had been approved for Medicare patients, "software updates for claims submissions and processing did not take effect until July 1," which meant
More news about: Robbins Geller Rudman & Dowd LLP
Nov 10, 2025, 09:00 ET Inspire Medical Systems, Inc. (INSP) Faces Investor Suit Over Disastrous Inspire V Launch-- Hagens Berman
onboarding criteria required prior to the purchase and implant of Inspire V." The company also said that, although Inspire V's CPT code was approved for Medicare patients, "software updates for claims submissions and processing did not take effect until July 1." This meant that
More news about: Hagens Berman Sobol Shapiro LLP
Oct 30, 2025, 16:05 ET SERA PROGNOSTICS ANNOUNCES CONFERENCE CALL AND WEBCAST OF THIRD QUARTER FISCAL YEAR 2025 FINANCIAL RESULTS ON NOVEMBER 13, 2025
market growth; potential third-party payer coverage and reimbursement; new reimbursement methodologies applicable to the PreTRM Test, including new CPT codes and payment rates for those codes; changes in FDA regulation of laboratory-developed tests; the intellectual property rights protecting our tests
More news about: Sera Prognostics, Inc.
Oct 30, 2025, 08:42 ET Collectly Expands End-to-End AI-Powered Patient Financial Experience with Launch of Billie, AI Agent for Eligibility & Benefits
simply return raw 271 data, Collectly's AI leverages a large language model (LLM). The model analyzes the 271 response alongside taxonomy codes, CPT and ICD codes, and historical claim trends to identify gaps, predict likely coverage, and flag edge cases such as specialty carve-outs. When a payer's
More news about: Collectly
Oct 24, 2025, 09:05 ET Intrinsic Therapeutics Announces that AMA Released CPT 2026 Code Set Including New CPT Code 63032 Describing Bone-Anchored Annular Closure, Effective January 1, 2026
This new add-on CPT code specifically describes the adjunctive placement of a bone-anchored annular closure device (Barricaid) following lumbar discectomy in patients with large annular defects. The CPT long descriptor reads: "with repair of annular defect
More news about: Intrinsic Therapeutics, Inc.
Oct 23, 2025, 08:33 ET Adhere+ Earns "Top Clinical Abstract" at 2025 "Business of Pain" Meeting
compliance with treatment protocols, leading to better health outcomes, and a reduction in related healthcare costs. The program aligns with several AMA CPT payment codes for a potential reimbursable benefit. Contact
More news about: Adhere+
Oct 22, 2025, 12:04 ET NEUROMARK® Now with Expanded Access on UnitedHealthcare's Medicare Advantage Policy for Posterior Nasal Nerve Ablation
Effective immediately, CPT 31242 is no longer considered experimental, removing a key barrier for ENT physicians treating chronic rhinitis. GALWAY, Ireland,
More news about: Neurent Medical
Oct 21, 2025, 08:33 ET Pain Consultants of East Tennessee Selected as the Initial "Flagship Office" to Demonstrate the Power of the Adhere+ Remote Therapeutic Monitoring Platform
compliance with treatment protocols, leading to better health outcomes, and a reduction in related healthcare costs. The program aligns with several AMA CPT payment codes for a potential reimbursable benefit. About Pain Consultants of East Tennessee
More news about: Adhere+
Oct 17, 2025, 17:58 ET Virtual Field Crosses 4 Million Eye Exams -- More Than All Other VR Platforms Combined
expanding diagnostic suite now goes beyond visual fields, offering 14 VR-based visual testing options that qualify for four reimbursable CPT codes. This enables practices to deliver comprehensive, data-connected testing from a single platform — while driving new ROI and billable
More news about: Virtual Field
Oct 15, 2025, 06:00 ET Newton™ Announces VSP Availability for Sequel™ Lenses, Expanding Access to Digital Eye Strain Relief Nationwide
and Sequel 67 designs with users experiencing digital eye strain symptoms, n=29 (Sequel 38), n=27 (Sequel 67). Neurolens Data on File: Intelliboost CPT Study 2025 - CVS-Q ² CooperVision (February 2024). "A New Look at Digital Eye Strain". Report of online survey results (2023):
More news about: Newton
Oct 14, 2025, 09:00 ET American Medical Association Grants Levee Medical Category III CPT Code for Placement of Voro® Urologic Scaffold
Medical Association's (AMA) CPT Editorial Panel has approved a Category III CPT add-on code applicable to the placement of the Voro® Urologic Scaffold when performed in conjunction with a radical prostatectomy procedure for patients with prostate cancer. The new CPT code is expected to become
More news about: Levee Medical
Oct 03, 2025, 12:19 ET IceCure Receives FDA Marketing Authorization for ProSense® Cryoablation for the Treatment of Low-Risk Breast Cancer in Women Aged 70 and Above
Initial reimbursement under the CPT III code which covers $3,800 of facility costs, with additional reimbursement coverage expected
More news about: IceCure Medical
Oct 01, 2025, 08:05 ET Sera Prognostics Names Dr. Tiffany Inglis Chief Medical Officer
market growth; potential third-party payer coverage and reimbursement; new reimbursement methodologies applicable to the PreTRM Test, including new CPT codes and payment rates for those codes; changes in FDA regulation of laboratory-developed tests; the intellectual property rights protecting our tests
More news about: Sera Prognostics, Inc.